Journal Profile | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Title | PHARMACEUTICAL STATISTICS | ||||||||||||||||||||||||
Journal Title Abbreviations | PHARM STAT | ||||||||||||||||||||||||
ISSN | 1539-1604 | ||||||||||||||||||||||||
E-ISSN | 1539-1612 | ||||||||||||||||||||||||
h-index | 33 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
Self-Citation Ratio (2020-2021) | 17.70% | ||||||||||||||||||||||||
期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||
Official Website | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1539-1612 | ||||||||||||||||||||||||
Online Manuscript Submission | http://mc.manuscriptcentral.com/pst-wiley | ||||||||||||||||||||||||
Open Access | No | ||||||||||||||||||||||||
Publisher | JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 | ||||||||||||||||||||||||
Subject Area | Medicine | ||||||||||||||||||||||||
Country/Area of Publication | ENGLAND | ||||||||||||||||||||||||
Publication Frequency | Quarterly | ||||||||||||||||||||||||
Year Publication Started | 2002 | ||||||||||||||||||||||||
Annual Article Volume | 63 | ||||||||||||||||||||||||
Gold OA文章占比 | |||||||||||||||||||||||||
OA期刊相关信息 | |||||||||||||||||||||||||
WOS期刊SCI分区 | |||||||||||||||||||||||||
Indexing (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1539-1604%5BISSN%5D | ||||||||||||||||||||||||
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
Competitiveness * | Data from Authors: Easy | ||||||||||||||||||||||||
Useful Links |
| ||||||||||||||||||||||||
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
|
First Previous 1 Next Last (To Page | |
Reviews on PHARMACEUTICAL STATISTICS: | Write a review |
Author: 陈超 Subject Area: Medicine Duration of Peer Review: 5.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2024-07-02 11:23:17 One article has been accepted, while another one was rejected. Currently, the third article is under revision. The review process is relatively fast compared to journals in the field of mathematics, and the reviewers' comments are quite professional. However, it is unclear why both small sections are in Zone 3, while the larger section is in Zone 4. ![]() ![]() |
Author: 宗室志涛 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2024-05-17 13:10:07 Review Speed: 6.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Statistical methods; Experience in Biostatistics: Submitted in September 22, reviewed by two reviewers, received comments in November, revised once, accepted in January 23 ![]() ![]() |
Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 12:04:47 Research Background: In recent years, the study of XX has gained increasing attention due to its potential applications in various fields. The development status of XX has also advanced significantly, with many research breakthroughs being made. Research Significance: Understanding XX is crucial for the advancement of technology and innovation in XX-related industries. Furthermore, the study of XX can provide valuable insights into XX-related phenomena, leading to potential solutions for existing problems. Research Development: Despite the progress made in the study of XX, there are still unresolved issues and challenges that need to be addressed. This motivates me to conduct further research in this area to contribute to the existing knowledge and potentially find new solutions to these challenges. Research Purpose: The specific objective of my research is to investigate the XX phenomenon in depth and explore its potential applications in various industries. By gaining a deeper understanding of XX, I aim to contribute to the advancement of technology and innovation in this field ![]() ![]() |
Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 11:06:34 Important documents, if available, can be used to provide evidence, but they may show different emphasis ![]() ![]() |
Author: 魂魄彦露 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-26 20:11:03 Is the important literature in the results or described in the introduction? ![]() ![]() |
Author: 魂魄彦露 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-26 12:26:51 What does the three-point introduction refer to? ![]() ![]() |
First Previous 1 Next Last (To Page |